Bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride
HealthData.Gov
Updated Mar 24, 2026
About this dataset
This is a prescription medication combining bismuth subcitrate potassium (140 mg), metronidazole (125 mg), and tetracycline hydrochloride (125 mg) in oral capsules. It's used to treat certain bacterial infections, like those caused by H. pylori. Manufactured by Endo USA, Inc., under ANDA 205770. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride
Access the FDA dataset for Bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025
Related datasets
- Bismuth subcitrate potassium, metronidazole and tetracycline hydrochlorideHealthData.Gov
- Bismuth subcitrate potassium, metronidazole, tetracycline hydrochlorideHealthData.Gov
- Bismuth subcitrate potassium, metronidazole, tetracycline hydrochlorideHealthData.Gov
- MetronidazoleHealthData.Gov
- MetronidazoleHealthData.Gov